Georgia Picks German Scientist To Lead Avian Vaccine Developments
Posted August 25, 2006
ATHENS, GA. — Egbert Mundt, a scientist from Germany, will lead efforts by the state of Georgia to develop avian vaccine development.
Mundt holds eight patents. Among them is one for a system to create vaccines based on reverse genetics. He will work at the University of Georgia as a Georgia Research Alliance Eminent Scholar. His most recent position was with the Federal Research Institute for Animal Health in Germany.
Mudt has helped develop a diagnostic test for avian influenza.
Georgia is among the bidders for the National Bio and Argo-Defense Facility. (North Carolina also is bidding for the project.)
Some $1.5 million was raised to endow a professorship for Mundt. The
Georgia Research Alliance